Patient decision-making about complementary and alternative medicine in cancer management: context and process

Current Oncology

Volumn 15, Issue S2, 2008, Pages S94-S100

  Balneaves, Lynda G ^a   Weeks, L ^b   Seely, D ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c CANADIAN COLLEGE OF NATUROPATHIC MEDICINE   (Canada)

Author keywords

communication; Complementary therapies; decision making process; health professionals; oncology

Indexed keywords

EID: 85127027718     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v15i0.280     Document Type: Article

References (48)

1. Charles C, Gafni A, Whelan T. Decision-making in the physician–patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 1999;49:651–61.
2. Diefenbach MA, Dorsey J, Uzzo RG, et al. Decision-making strategies for patients with localized prostate cancer. Semin Urol Oncol 2002;20:55–62.
3. Gattellari M, Voigt KJ, Butow PN, Tattersall MH. When the treatment goal is not cure: are cancer patients equipped to make informed decisions? J Clin Oncol 2002;20:503–13.
4. Robinson A, Thomson R. Variability in patient preferences for participating in medical decision making: implication for the use of decision support tools. Qual Health Care 2001;10(suppl 1):i34–8.
5. Elit L, Charles C, Gold I, et al. Women’s perceptions about treatment decision making for ovarian cancer. Gynecol Oncol 2003;88:89–95.
6. Henman MJ, Butow PN, Brown RF, Boyle F, Tattersall MH. Lay constructions of decision-making in cancer. Psychooncology 2002;11:295–306.
7. Sainio C, Eriksson E, Lauri S. Patient participation in decision making about care. Cancer Nurs 2001;24:172–9.
8. Sanders T, Skevington S. Do bowel cancer patients participate in treatment decision-making? Findings from a qualitative study. Eur J Cancer Care (Engl) 2003;12:166–75.
9. Davison BJ, Gleave ME, Goldenberg SL, Degner LF, Hoffart D, Berkowitz J. Assessing information and decision preferences of men with prostate cancer and their partners. Cancer Nurs 2002;25:42–9.
10. Degner LF, Kristjanson LJ, Bowman D, et al. Information needs and decisional preferences of women with breast cancer. JAMA 1997;277:1485–92.
11. Balneaves LG, Bottorff JL, Hislop TG, Herbert C. Levels of commitment: exploring complementary therapy use by women with breast cancer. J Altern Complement Med 2006;12:459–66.
12. Eng J, Ramsum D, Verhoef M, Guns E, Davison BJ, Gallagher R. A population based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther 2003;2:212–16.
13. Deng GE, Cassileth BR, Cohen L, et al. Integrative oncology practice guidelines. J Soc Integr Oncol 2007;5:65–84.
14. Balneaves LG, Truant TL, Kelly M, Verhoef MJ, Davison BJ. Bridging the gap: decision-making processes of women with breast cancer using complementary and alternative medicine (CAM). Support Care Cancer 2007;15:973–83.
15. Boon H, Brown JB, Gavin A, Kennard MA, Stewart M. Breast cancer survivors’ perceptions of complementary/alternative medicine (CAM): making the decision to use or not to use. Qual Health Res 1999;9:639–53.
16. Boon H, Brown JB, Gavin A, Westlake K. Men with prostate cancer: making decisions about complementary/alternative medicine. Med Decis Making 2003;23:471–9.
17. Montbriand MJ. Alternative therapies as control behaviours used by cancer patients. J Adv Nurs 1995;22:646–54.
18. Truant T, Bottorff JL. Decision making related to complementary therapies: a process of regaining control. Patient Educ Couns 1999;38:131–42.
19. Buettner C, Kroenke CH, Phillips RS, Davis RB, Eisenberg DM, Holmes MD. Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses’ health study. Breast Cancer Res Treat 2006;100:219–27.
20. Kimby CK, Launso L, Henningsen I, Langgaard H. Choice of unconventional treatment by patients with cancer. J Altern Complement Med 2003;9:549–61.
21. Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A. Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther 2005;4:274–86.
22. Eng K, Feeny D. Comparing the health of low income and less well educated groups in the United States and Canada. Popul Health Metr 2007;5:10.
23. Patterson RE, Neuhouser ML, Hedderson MM, et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and cost. J Altern Complement Med 2002;8:477–85.
24. Broom A, Tovey P. The dialectical tension between individuation and depersonalization in cancer patients’ mediation of complementary, alternative and biomedical cancer treatments. Sociology 2007;41:1021–39.
25. Rotter JB. Generalized expectancies for internal versus external control of reinforcement. Psychol Monogr 1966;80:1–28.
26. Balneaves LG, Kristjanson LJ, Tataryn D. Beyond convention: describing complementary therapy use by women living with breast cancer. Patient Educ Couns 1999;38:143–53.
27. Bishop FL, Yardley L. Constructing agency in treatment decisions: negotiating responsibility in cancer. Health (London) 2004;84:465–82.
28. Davidson R, Geoghegan L, McLaughlin L, Woodward R. Psychological characteristics of cancer patients who use complementary therapies. Psychooncology 2005;14:187–95.
29. Turton P, Cooke H. Meeting the needs of people with cancer for support and self-management. Complement Ther Nurs Midwifery 2000;6:130–7.
30. Salmenpera L. The use of complementary therapies among breast and prostate cancer patients in Finland. Eur J Cancer Care (Engl) 2002;11:44–50.
31. Rakovitch E, Pignol JP, Chartier C, et al. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Res Treat 2005;90:139–48.
32. Lupton D. Theoretical perspectives on medicine and society. In: Lupton D, ed. Medicine As Culture. 2nd ed. London: Sage; 1994:5–21.
33. Seale C. Health and Media. London: Sage; 2003.
34. Weeks L, Verhoef M, Scott C. Presenting the alternative: cancer and complementary and alternative medicine in the Canadian print media. Support Care Cancer 2007;15:931–8.
35. Evans M, Shaw A, Thompson EA, et al. Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med 2007;7:25.
36. Öhlén J, Balneaves LG, Bottorff JL, Brazier AS. The influence of significant others in complementary and alternative decisions by cancer patients. Soc Sci Med 2006;63:1625–36.
37. Singh H, Maskarinec G, Shumay DM. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer. Integr Cancer Ther 2005;4:187–94.
38. Verhoef MJ, Mulkins A, Carlson LE, Hilsden RJ, Kania A. Assessing the role of evidence in patients’ evaluation of complementary therapies: a quality study. Integr Cancer Ther 2007;6:345–53.
39. Roberts CS, Baker F, Hann D, et al. Patient–physician communication regarding use of complementary therapies during cancer treatment. J Psychosoc Oncol 2005;23:35–60.
40. Verhoef MJ, Boon HS, Page SA. Talking to cancer patients about complementary therapies: is it the physician’s responsi bility? Curr Oncol 2008;15(suppl 2):S88–S93.
41. Evans MA, Shaw AR, Sharp DJ, et al. Men with cancer: is their use of complementary and alternative medicine a response to needs unmet by conventional care? Eur J Cancer Care (Engl) 2007;16:517–25.
42. Montbriand MJ. Decision tree model describing alternate health care choices made by oncology patients. Cancer Nurs 1995;18:104–17.
43. Lengacher CA, Bennett MP, Kip KE, Gonzalez L, Jacobsen P, Cox CE. Relief of symptoms, side effects, and psychological distress through use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum 2006;33:97–104.
44. Hann D, Allen S, Ciambrone D, Shah A. Use of complementary therapies during chemotherapy: influence of patients’ satisfaction with treatment decision making and the treating oncologist. Integr Cancer Ther 2006;5:224–31.
45. Shumay DM, Maskarinec G, Gotay CC, Heiby EM, Kakai H. Determinants of the degree of complementary and alternative medicine use among patients with cancer. J Altern Complement Med 2002;8:661–71.
46. Boyd DB. Integrative oncology: the last ten years—a personal retrospective. Altern Ther Health Med 2007;13:56–64.
47. Corbin Winslow L, Shapiro H. Physician want education about complementary and alternative medicine to enhance communication with their patients. Arch Intern Med 2002;162:1176–81.
48. Hessig RE, Arcand LL, Frost MH. The effects of an educational intervention on oncology nurses’ attitude, perceived knowledge, and self-reported application of complementary therapies. Oncol Nurs Forum 2004;31:71–8.